Article Text

Download PDFPDF

Can biomarkers differentiate psoriatic arthritis from osteoarthritis?
  1. Jian Tian1,
  2. Chao Cheng2,
  3. Fangjie Zhang3
  1. 1Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China
  2. 2Department of Orthopaedics, Yiyang Central Hospital, Clinical Medical Technology Demonstration Base for Minimally Invasive and Digital Orthopaedics in Hunan Province, Yiyang, China
  3. 3Department of Emergency Medicine, Xiangya Hospital, Central South University, Changsha, China
  1. Correspondence to Dr Fangjie Zhang, Department of Emergency Medicine, Xiangya Hospital, Central South University, Changsha 410008, China; zhangfj11{at}163.com

Statistics from Altmetric.com

We read with deep interest the article by Chandran V et al,1 which was aimed at identifying soluble biomarkers that differentiate psoriatic arthritis (PsA) from osteoarthritis (OA). Their results showed that cartilage oligomeric matrix protein,monocyte chemoattractant protein-1 and nerve growth factor were found to be independently associated with PsA versus OA in a multivariate analysis, and they obtained the conclusion that a panel of four biomarkers may distinguish PsA from OA. We really appreciate the work that has been done by the authors. However, there are some worthwhile issues that need to be explored.

First, the conclusion ‘A panel of four biomarkers may distinguish PsA from OA’ might be not appropriate. The potential meaning of ‘differentiate PsA from OA’ is that detection of these biomarkers helps to diagnose and distinguish PsA from OA when the clinical manifestations of the two diseases are …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles